HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morihito Okada Selected Research

Triple Negative Breast Neoplasms

5/2022The TILs-US score on ultrasonography can predict the pathological response to neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive and triple-negative breast cancer.
9/2021Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study).
6/2020Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer.
4/2019Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT.
4/2015The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial.
1/2015The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.
11/2011A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Morihito Okada Research Topics

Disease

108Neoplasms (Cancer)
11/2022 - 08/2003
70Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 07/2004
55Lung Neoplasms (Lung Cancer)
01/2022 - 09/2004
35Breast Neoplasms (Breast Cancer)
05/2022 - 03/2009
32Adenocarcinoma of Lung
11/2022 - 09/2003
30Esophageal Squamous Cell Carcinoma
07/2022 - 08/2014
25Esophageal Neoplasms (Esophageal Cancer)
05/2022 - 09/2008
20Adenocarcinoma
11/2022 - 12/2003
17Neoplasm Metastasis (Metastasis)
07/2022 - 03/2009
17Malignant Mesothelioma
01/2022 - 03/2007
15Lymphatic Metastasis
11/2022 - 12/2012
11Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021 - 03/2006
10Mesothelioma
01/2022 - 03/2007
8Stomach Neoplasms (Stomach Cancer)
04/2015 - 12/2008
7Triple Negative Breast Neoplasms
05/2022 - 11/2011
7Disease Progression
01/2022 - 05/2012
7Interstitial Lung Diseases (Interstitial Lung Disease)
12/2021 - 09/2012
6Fistula
01/2022 - 04/2011
6Carcinoma (Carcinomatosis)
02/2017 - 03/2007
5Margins of Excision
01/2021 - 01/2018
3Vomiting
10/2022 - 06/2019
3Nausea
10/2022 - 06/2019
3Lung Injury
01/2022 - 12/2002
3Febrile Neutropenia
07/2021 - 06/2012
3Pneumonia (Pneumonitis)
06/2021 - 03/2015
3Bronchial Fistula
02/2021 - 11/2012
3Anorexia
12/2020 - 06/2019
3Hemorrhage
06/2019 - 03/2007
3Carcinogenesis
01/2019 - 05/2011
3Pathologic Complete Response
03/2018 - 07/2012
3Hyperplasia
03/2018 - 01/2005
3Inflammation (Inflammations)
01/2017 - 12/2002
3Hypoxia (Hypoxemia)
12/2015 - 06/2004
3Colorectal Neoplasms (Colorectal Cancer)
11/2014 - 11/2008
2Emphysema
07/2021 - 03/2014
2Fibrosis (Cirrhosis)
06/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

18Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2009
16Biological ProductsIBA
05/2021 - 09/2003
15Biomarkers (Surrogate Marker)IBA
07/2022 - 09/2003
13Carcinoembryonic AntigenIBA
03/2019 - 08/2003
12Fluorouracil (Carac)FDA LinkGeneric
08/2019 - 12/2008
11ErbB Receptors (EGF Receptor)IBA
11/2022 - 08/2010
11Deoxyglucose (2 Deoxy D glucose)IBA
01/2022 - 07/2011
10Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2011
9Docetaxel (Taxotere)FDA Link
07/2021 - 12/2008
8NivolumabIBA
01/2022 - 09/2019
7Pemetrexed (MTA)FDA Link
01/2022 - 03/2009
7Paclitaxel (Taxol)FDA LinkGeneric
09/2021 - 06/2008
6Tyrosine Kinase InhibitorsIBA
01/2022 - 04/2016
6Bevacizumab (Avastin)FDA Link
01/2022 - 04/2016
6Estrogen ReceptorsIBA
09/2021 - 10/2011
6Phenobarbital (Luminal)FDA Link
09/2021 - 02/2015
5Pharmaceutical PreparationsIBA
11/2021 - 03/2013
5Calbindin 2IBA
01/2020 - 03/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 03/2006
4Immune Checkpoint InhibitorsIBA
01/2022 - 09/2019
4PlatinumIBA
01/2022 - 06/2015
4Monoclonal AntibodiesIBA
01/2022 - 01/2012
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2021 - 06/2009
4human ERBB2 proteinIBA
09/2021 - 09/2013
4Claudin-4IBA
03/2019 - 01/2017
4Carboplatin (JM8)FDA LinkGeneric
10/2018 - 06/2008
3AlbuminsIBA
10/2022 - 01/2018
3Estrogens (Estrogen)FDA Link
09/2021 - 09/2013
3taxaneIBA
09/2021 - 04/2015
3Trastuzumab (Herceptin)FDA Link
07/2021 - 11/2011
3LigandsIBA
03/2021 - 01/2020
3RNA (Ribonucleic Acid)IBA
06/2020 - 03/2009
3Hormones (Hormone)IBA
06/2019 - 10/2013
3Messenger RNA (mRNA)IBA
08/2017 - 03/2006
3AntigensIBA
01/2017 - 09/2003
3Indicators and Reagents (Reagents)IBA
01/2016 - 09/2004
3Cell Adhesion Molecule-1IBA
08/2015 - 09/2003
3Orotate PhosphoribosyltransferaseIBA
12/2008 - 09/2008
2C-Reactive ProteinIBA
10/2022 - 01/2017
2fosaprepitantFDA Link
10/2022 - 06/2022
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2022 - 01/2019
2Vinorelbine (Navelbine)FDA LinkGeneric
01/2022 - 01/2021
2Gefitinib (Iressa)FDA Link
01/2022 - 04/2016
2cremophorIBA
09/2021 - 04/2015
2Albumin-Bound PaclitaxelFDA Link
09/2021 - 04/2015
2B7-H1 AntigenIBA
03/2021 - 01/2020

Therapy/Procedure

53Segmental Mastectomy (Lumpectomy)
11/2022 - 09/2004
38Therapeutics
03/2022 - 06/2008
29Neoadjuvant Therapy
05/2022 - 03/2011
25Drug Therapy (Chemotherapy)
10/2022 - 09/2008
21Lymph Node Excision (Lymph Node Dissection)
01/2022 - 03/2006
19Esophagectomy
05/2022 - 05/2009
16Adjuvant Chemotherapy
11/2022 - 09/2013
14Chemoradiotherapy
05/2022 - 03/2011
14Operative Surgical Procedures
10/2021 - 01/2005
10Radiotherapy
01/2022 - 06/2016
10Pneumonectomy (Lung Volume Reduction)
02/2021 - 03/2007
5Induction Chemotherapy
01/2022 - 03/2009
3Immunotherapy
11/2021 - 01/2021
3Gastrectomy
01/2020 - 02/2010
3Aftercare (After-Treatment)
01/2019 - 09/2012
3Stents
01/2019 - 04/2011
3Thoracotomy
01/2017 - 03/2011
3Operative Time
06/2016 - 03/2007